• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase II trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group.

作者信息

Buesa J M, Mouridsen H T, Santoro A, Somers R, Bramwell V, van Oosterom A T, Wagener T, Vendrik C, Thomas D

出版信息

Cancer Treat Rep. 1984 Apr;68(4):683-4.

PMID:6713423
Abstract
摘要

相似文献

1
Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase II trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group.低剂量甲氨蝶呤治疗晚期软组织肉瘤：欧洲癌症研究与治疗组织（EORTC）软组织和骨肉瘤研究组的II期试验
Cancer Treat Rep. 1984 Apr;68(4):683-4.
2
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.环磷酰胺与异环磷酰胺对比：一项针对成人软组织肉瘤的随机II期试验。欧洲癌症研究与治疗组织[EORTC]软组织和骨肉瘤研究组。
Cancer Chemother Pharmacol. 1993;31 Suppl 2:S180-4.
3
Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.异环磷酰胺两种研究性给药方案与标准剂量阿霉素治疗晚期或转移性软组织肉瘤的Ⅲ期试验：欧洲癌症研究与治疗组织软组织和骨肉瘤研究组的研究
J Clin Oncol. 2007 Jul 20;25(21):3144-50. doi: 10.1200/JCO.2006.09.7717.
4
Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.氯脲霉素治疗晚期软组织肉瘤：欧洲癌症研究与治疗组织软组织和骨肉瘤组的一项II期试验
Cancer Treat Rep. 1981 May-Jun;65(5-6):509-11.
5
Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).序贯剂量密集多柔比星与异环磷酰胺治疗晚期软组织肉瘤：西班牙肉瘤研究小组（GEIS）的一项II期试验
Cancer. 2004 Apr 1;100(7):1498-506. doi: 10.1002/cncr.20115.
6
Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study.去水卫矛醇治疗晚期软组织和骨肉瘤的II期试验：一项西南肿瘤协作组的研究
Cancer Treat Rep. 1979 Apr;63(4):553-5.
7
Results of the Royal Marsden Hospital second soft tissue sarcoma schedule (STS II) chemotherapy regimen in the management of advanced sarcoma.皇家马斯登医院第二软组织肉瘤治疗方案（STS II）化疗方案用于晚期肉瘤治疗的结果。
Cancer Treat Rep. 1980 Apr-May;64(4-5):689-92.
8
Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.序贯高剂量阿霉素与异环磷酰胺对比标准剂量阿霉素治疗晚期软组织肉瘤患者的疗效：西班牙肉瘤研究小组的一项开放标签随机II期研究
J Clin Oncol. 2009 Apr 10;27(11):1893-8. doi: 10.1200/JCO.2008.19.2930. Epub 2009 Mar 9.
9
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma Group.重组人粒细胞-巨噬细胞集落刺激因子联合化疗治疗晚期成人软组织肉瘤：欧洲癌症研究与治疗组织软组织和骨肉瘤组的早期结果
Cancer Chemother Pharmacol. 1993;31 Suppl 2:S241-4.
10
Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).脂质体阿霉素（楷莱）用于晚期经预处理的软组织肉瘤：意大利肉瘤研究组（ISG）的一项II期研究
Anticancer Res. 2000 Jan-Feb;20(1B):485-91.

引用本文的文献

1
Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review.药物干预在晚期软组织肉瘤二线或更后线治疗中的疗效和安全性：系统评价。
BMC Cancer. 2013 Aug 13;13:385. doi: 10.1186/1471-2407-13-385.